Effect of losartan versus afenolol on aortic valve sclerosis (a LIFE substudy)OLSEN, Michael H; WACHTELL, Kristian; DEVEREUX, Richard B et al.The American journal of cardiology. 2004, Vol 94, Num 8, pp 1076-1080, issn 0002-9149, 5 p.Article

Low-affinity state betal-adrenoceptor-induced vasodilation in SHRMOHAMED YASSINE MALLEM; RECULEAU, Olivier; LE COZ, Olivier et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 8, pp 1463-1467, issn 0196-9781, 5 p.Conference Paper

A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked ratsLOH, K. P; LOW, L. S; WONG, W. H et al.Neuroscience letters. 2006, Vol 398, Num 1-2, pp 28-33, issn 0304-3940, 6 p.Article

Angiotensin II can induce and potentiate shape change in human platelets : effect of losartanJAGROOP, I. A; MIKHAILIDIS, D. P.Journal of human hypertension. 2000, Vol 14, Num 9, pp 581-585, issn 0950-9240Article

Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injuryMOON, Michael C; MOLNAR, Katerina; YAU, Lorraine et al.Journal of vascular surgery. 2004, Vol 40, Num 1, pp 130-137, issn 0741-5214, 8 p.Article

Angiotensin II antagonistsSMITH, R. D; CUNNINGHAM, G; KIVLIGHN, S. D et al.Emerging drugs. 1998, Vol 3, pp 81-93, issn 1361-9195Article

Effect of losartan on human platelet activationGUERRA-CUESTA, J. I; MONTON, M; LOPEZ-FARRE, A et al.Journal of hypertension. 1999, Vol 17, Num 3, pp 447-452, issn 0263-6352Article

Inhibiteurs des récepteurs AT1 à l'angiotensine II = Inhibitors of angiotensin II AT1 receptorsBOUTOUYRIE, P.STV. Sang thrombose vaisseaux. 1999, Vol 11, Num 6, pp 479-484, issn 0999-7385Article

Pharma-clinics. Le médicament du mois : Le losartan (Cozaar®) = Losartan:drug of the monthSCHEEN, A. J.RMLG. Revue médicale de Liège. 1997, Vol 52, Num 5, pp 367-369, issn 0370-629XArticle

Pharmacokinetic- pharmacodynamic interactions of candesartan cilexetil and losartanAZIZI, M; CHATELLIER, G; GUYENE, T.-T et al.Journal of hypertension. 1999, Vol 17, Num 4, pp 561-568, issn 0263-6352Article

Solubilities of losartan polymorphsCROCKER, L. S; MCCAULEY, J. A.Pharmazie. 1997, Vol 52, Num 1, issn 0031-7144, p. 72Article

Inhibition of angiotensin II pressor response and ex vivo angiotensin II radioligand binding by candesartan cilexetil and losartan in healthy human volunteersBELZ, G. G; FUCHS, B; MALERCZYK, C et al.Journal of human hypertension. 1997, Vol 11, pp S45-S47, issn 0950-9240, SUP2Article

A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinityARSENAULT, Jason; LEHOUX, Julie; LANTHIER, Luc et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 6, pp 377-388, issn 1744-6872, 12 p.Article

Measuring Angiotensin-I Converting Enzyme Inhibitory Activity by Micro Plate Assays: Comparison Using Marine Cryptides and Tentative Threshold Determinations with Captopril and LosartanBEN HENDA, Yesmine; LABIDI, Anis; ARNAUDIN, Ingrid et al.Journal of agricultural and food chemistry (Print). 2013, Vol 61, Num 45, pp 10685-10690, issn 0021-8561, 6 p.Article

CORD: Comparison of Recommended Doses of ace inhibitors and angiotensin II receptor blockersSPINAR, J; VITOVEC, J; SOUCEK, M et al.International journal of cardiology. 2010, Vol 144, Num 2, pp 293-294, issn 0167-5273, 2 p.Article

The Ghent Marfan Trial — A randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockersMÖBERG, Katarina; DE NOBELE, Sylvia; DE PAEPE, Anne et al.International journal of cardiology. 2012, Vol 157, Num 3, pp 354-358, issn 0167-5273, 5 p.Article

Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failurePECHTER, Ülle; AUNAPUU, Marina; RIISPERE, Zivile et al.Nephron. 2004, Vol 97, Num 2, pp e33-e37, issn 0028-2766Article

Blockade of 5-HT₃ receptors at septal area increase blood pressure in unanaesthetized ratsURZEDO-RODRIGUES, Lilia S; FERREIRA, Hilda S; ALMEIDA, Daniela O et al.Autonomic neuroscience : basic & clinical. 2011, Vol 159, Num 1-2, pp 51-61, issn 1566-0702, 11 p.Article

Pressor response to CSF sodium in mice: mediation by a ouabain-like substance and renin-angiotensin system in the brainVAN HUYSSE, James W; XIAOHONG HOU.Brain research. 2004, Vol 1021, Num 2, pp 219-231, issn 0006-8993, 13 p.Article

ANGIOTENSIN III MODULATES THE NOCICEPTIVE CONTROL MEDIATED BY THE PERIAQUEDUCTAL GRAY MATTERPELEGRINI-DA-SILVA, A; ROSA, E; GUETHE, L. M et al.Neuroscience. 2009, Vol 164, Num 3, pp 1263-1273, issn 0306-4522, 11 p.Article

Central injection of hypertonic saline activates angiotensin II-sensitive neurons in the anterior hypothalamic area of ratsHAGIWARA, Yukihiko; SASAKI, Youhei; FUKUMORI, Ryuji et al.Brain research. 2005, Vol 1046, Num 1-2, pp 165-171, issn 0006-8993, 7 p.Article

NATRIOREXIGENIC EFFECT OF DAMGO IS DECREASED BY BLOCKING AT1 RECEPTORS IN THE CENTRAL NUCLEUS OF THE AMYGDALAYAN, J.-B; SUN, H.-L; QIAO, H et al.Neuroscience. 2014, Vol 262, pp 9-20, issn 0306-4522, 12 p.Article

Losartan Chemistry and Its Effects via AT1 Mechanisms in the KidneyFEICHAO XU; CAIPING MAO; YUJUAN LIU et al.Current medicinal chemistry. 2009, Vol 16, Num 28, pp 3701-3715, issn 0929-8673, 15 p.Article

The cardiovascular response of normal rats to dual lesion of the subfomical organ and area postrema at rest and to chronic losartanCOLLISTER, John P; NAHEY, David B.Brain research. 2009, Vol 1302, pp 118-124, issn 0006-8993, 7 p.Article

Losartan attenuates bleomycin-induced pulmonary fibrosis in ratsHONG WEI YAO; JIAN PING ZHU; MENG HUI ZHAO et al.Respiration (Basel). 2006, Vol 73, Num 2, pp 236-242, issn 0025-7931, 7 p.Article